Optibrium, Intellegens and Medicines Discovery Catapult combine their expertise in drug discovery and AI research CAMBRIDGE, and MACCLESFIELD, UK – The consortium behind the DeepADMET project set up to advance artificial intelligence (AI) technologies for drug discovery, today announced the successful conclusion of this project which was funded by Innovate UK, the UK’s innovation agency. Optibrium […]
Associated Collaboration with the New York Genome Center to Expand Patient Access to Advanced Genomic Technologies New York — Seeking to advance the scope of precision medicine, Weill Cornell Medicine, NewYork-Presbyterian Hospital, and Illumina, Inc. are entering into a collaboration to sequence the complete human genomes of thousands of consenting patients, in order to identify genetic alterations driving disease […]
MINNEAPOLIS — Bio-Techne Corporation (NASDAQ: TECH) and Regulus Therapeutics (NASDAQ: RGLS) announced a collaboration to support Regulus with biomarker analysis for the clinical development of RGLS4326, an Autosomal Dominant Polycystic Kidney Disease (ADPKD) treatment. Regulus has utilized two Bio-Techne branded product lines, ProteinSimple and Exosome Diagnostics, to aid in their clinical trial patient testing. RGLS4326 […]
The partnership launches RoosterBio’s first international platform with off-the-shelf working cell banks and hMSC bioprocess media products in Asia FREDERICK, Md. — RoosterBio, Inc, a leading supplier of innovative cellular therapy bioprocess tools and scalable manufacturing solutions for regenerative medicine, today announced it entered into an exclusive agency agreement with Sartorius Korea Biotech, a subsidiary of the […]
DUBLIN, Ireland & Frankfurt a.M., Germany: ERS Genomics Limited, which was formed to provide broad access to the foundational CRISPR/Cas9 intellectual property co-owned by Dr. Emmanuelle Charpentier, and Vivlion GmbH, a startup company providing next generation CRISPR/Cas gRNA libraries and screening services for the global R&D market, today announced a non-exclusive license agreement granting Vivlion® […]
Sanyou signs two commercial-use licenses for Horizon’s gene-edited CHO-K1 GS knockout cell line, for use in biotherapeutic pipeline development and contract research services Cambridge, UK, and Shanghai, China: Horizon Discovery Group plc (LSE: HZD) (“Horizon”, “the Company” or “the Group”), a global leader in the application of gene editing and gene modulation for cell line engineering, […]
Additional Illumina assays to be combined with the PierianDx platform to reduce time, cost, and complexity of genomic reporting PierianDx, the leading clinical genomics informatics company, today announced an expanded partnership with Illumina to enable PierianDx genomic reporting solutions for use with AmpliSeq™ for Illumina® Focus Panel, AmpliSeq™ for Illumina® Myeloid Panel and the TruSight™ Hereditary Cancer […]
Banner Industries is pleased to announce that it recently formed a partnership with Atonarp, Inc., effective October 15, 2020. Atonarp, a leading manufacturer of molecular diagnostics products, is spearheading the digital transformation of advanced molecular analysis and quantification in the industrial and healthcare space. Atonarp’s miniature spectrometers capture process-specific data, then translate that data into […]
WITec GmbH, the German manufacturer of high-performance Raman, AFM, SNOM, and correlative nano-analytical microscopy systems, announces a new cooperation in Japan for particle analysis. Dr. Yutaka Kameda, Associate Professor at the Chiba Institute of Technology (CIT) in Japan, and his team have been working very successfully for several years on the analysis of microplastics in […]
As of November 2020, John Morris Group will be the new distributor for Alpha MOS sensory analysis solutions in Australia and New Zealand. The John Morris Group is excited to announce that, as of the 27th November 2020, it will be the new distributor for Alpha MOS sensory analysis solutions in Australia and New Zealand. Together, the two companies plan […]
Pay Invoice
Latest Blogs
-
EU Roadmap Provides Further Impetus for New Approach Methodologies
June 29, 2026 12:56 pm
-
MOBILion Expands into Proteomics MS Market
April 30, 2026 5:05 pm
-
Carterra Introduces Faster SPR
March 27, 2026 7:26 pm
Sitemap
Your Data and Privacy
About Us
IBO (Instrument Business Outlook) is a twice-monthly newsletter aimed at providing decision-makers with the latest and most complete information available on the life science and analytical instrument industry, and lab product markets. IBO delivers the latest curated industry news, information and trends, as well as SDi data and analysis to deliver the maximum in industry insight with a minimum time investment for executives and investors.
